Accessibility Menu
HilleVax logo

HilleVax

(NASDAQ) HLVX

This security has been delisted. This page is retained for historical reference.

HLVX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

HLVX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-7.58%

Return on Capital

-86.76%

Return on Assets

-6.48%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$77.12M

EBITDA

-$66.58M

Operating Cash Flow

-$59.52M

Capital Expenditure

-$1.82M

Free Cash Flow

-$61.34M

Cash & ST Invst.

$159.55M

Total Debt

$23.54M

HilleVax Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

14

N/A

Net Income

-$5.27M

+87.1%

EBITDA

-$4.79M

+87.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

$159.55M

-34.9%

Total Debt

$23.54M

-56.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$19.91M

-9.1%

Short Term Debt

$3.63M

-88.9%

Return on Assets

-6.48%

N/A

Return on Invested Capital

-8.64%

N/A

Free Cash Flow

-$789.00K

+97.4%

Operating Cash Flow

-$789.00K

+97.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
JNCEJounce Therapeutics, Inc.
$1.88+0.00%
TRMLTourmaline Bio, Inc.
$47.98+0.00%
CYTCyteir Therapeutics, Inc.
$3.02-2.27%
AADIAadi Bioscience, Inc.
$2.05-2.38%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.55-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.73+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.12-0.01%
ONDSOndas
$7.54+0.03%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.